I'm not sure that's entirely correct. The first timeline we saw for azer-cel (at the time of purchase) targeted Q3 2024 for a Phase 1b readout, so 2H 2024 is still accurate.
The more recent JPM slides show 2 updates for azer-cel across 2024 one in Q2 (enrolment) and one in Q3 (readout). So I don't think the timeline there has slipped at all?
And as far as no immediate updates, I would think, given Vaxinia's preliminary enrolment update of April 24 '24, that the next data cut would not be too far off. To speculate, I *think* they would want to see all Cohort 5 patients cross the 42 day mark first. So as of April 24, there are still 7 Cohort 5 patients that have not yet had their 42 day scan.
Perhaps June for the next cut? Or maybe we're lucky and will see something mid May.
GLTAH.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.001(1.69%) |
Mkt cap ! $439.1M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.1¢ | 5.8¢ | $1.072M | 18.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85851 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 335299 | 3 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.1¢ |
Change
0.001 ( 2.37 %) |
||||
| Open | High | Low | Volume | ||
| 5.9¢ | 6.1¢ | 5.8¢ | 7197252 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| IMU (ASX) Chart |